Published in Exp Neurol on November 21, 2008
The Wobbler mouse model of amyotrophic lateral sclerosis (ALS) displays hippocampal hyperexcitability, and reduced number of interneurons, but no presynaptic vesicle release impairments. PLoS One (2013) 1.39
Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat Commun (2015) 1.24
Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis. J Physiol (2011) 1.15
Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability. J Neurophysiol (2013) 0.98
Blockade of persistent sodium currents contributes to the riluzole-induced inhibition of spontaneous activity and oscillations in injured DRG neurons. PLoS One (2011) 0.97
Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis. Mol Neurobiol (2011) 0.96
Selective mitochondrial Ca2+ uptake deficit in disease endstage vulnerable motoneurons of the SOD1G93A mouse model of amyotrophic lateral sclerosis. J Physiol (2013) 0.93
Early pathogenesis in the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Cell Biochem (2012) 0.92
Persistent inward currents in spinal motoneurons: important for normal function but potentially harmful after spinal cord injury and in amyotrophic lateral sclerosis. Clin Neurophysiol (2010) 0.91
Effect of prolonged riluzole exposure on cultured motoneurons in a mouse model of ALS. J Neurophysiol (2011) 0.89
Left-shifted nav channels in injured bilayer: primary targets for neuroprotective nav antagonists? Front Pharmacol (2012) 0.87
The puzzling case of hyperexcitability in amyotrophic lateral sclerosis. J Clin Neurol (2013) 0.86
Links between electrophysiological and molecular pathology of amyotrophic lateral sclerosis. Integr Comp Biol (2011) 0.83
Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial. EBioMedicine (2015) 0.83
Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat Rev Neurol (2016) 0.82
Hyperexcitability, persistent Na+ conductances and neurodegeneration in amyotrophic lateral sclerosis. Exp Neurol (2009) 0.80
Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc Natl Acad Sci U S A (2016) 0.79
Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease. Neurotherapeutics (2016) 0.79
Axonal Excitability in Amyotrophic Lateral Sclerosis : Axonal Excitability in ALS. Neurotherapeutics (2016) 0.79
Intrinsic and synaptic homeostatic plasticity in motoneurons from mice with glycine receptor mutations. J Neurophysiol (2014) 0.77
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression. Neurology (2016) 0.77
Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS. Neurobiol Dis (2016) 0.76
Reach task-associated excitatory overdrive of motor cortical neurons following infusion with ALS-CSF. J Neural Transm (Vienna) (2013) 0.76
Stronger is not always better: could a bodybuilding dietary supplement lead to ALS? Exp Neurol (2010) 0.76
Mutant SOD1 protein increases Nav1.3 channel excitability. J Biol Phys (2016) 0.75
Effect of fluoxetine on disease progression in a mouse model of ALS. J Neurophysiol (2014) 0.75
INaP selective inhibition reverts precocious inter- and motorneurons hyperexcitability in the Sod1-G93R zebrafish ALS model. Sci Rep (2016) 0.75
Calretinin and Neuropeptide Y interneurons are differentially altered in the motor cortex of the SOD1(G93A) mouse model of ALS. Sci Rep (2017) 0.75
Chronic EMGs in treadmill running SOD1 mice reveal early changes in muscle activation. J Physiol (2017) 0.75
Changes in the excitability of neocortical neurons in a mouse model of amyotrophic lateral sclerosis are not specific to corticospinal neurons and are modulated by advancing disease. J Neurosci (2017) 0.75
Altered excitability of motor neurons in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett (2003) 1.17
Enhancement of learning and memory after activation of cerebral Rho GTPases. Proc Natl Acad Sci U S A (2007) 1.17
Voltage-dependent sodium channels in spinal cord motor neurons display rapid recovery from fast inactivation in a mouse model of amyotrophic lateral sclerosis. J Neurophysiol (2006) 1.11
Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons. Neuroreport (2002) 0.98
Rapid constitutive and ligand-activated endocytic trafficking of P2X receptor. J Neurochem (2009) 0.97
Cu/Zn-superoxide dismutase (GLY93-->ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture. Neurobiol Dis (2004) 0.96
Oxidative stress in stroke pathophysiology validation of hydrogen peroxide metabolism as a pharmacological target to afford neuroprotection. Int Rev Neurobiol (2009) 0.95
MicroRNA-92 modulates K(+) Cl(-) co-transporter KCC2 expression in cerebellar granule neurons. J Neurochem (2009) 0.93
Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia. Br J Pharmacol (2012) 0.91
Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole. J Neurosci Res (2004) 0.90
Brivaracetam (ucb 34714) inhibits Na(+) current in rat cortical neurons in culture. Epilepsy Res (2009) 0.89
Identification of distinct cellular pools of interleukin-1beta during the evolution of the neuroinflammatory response induced by transient middle cerebral artery occlusion in the brain of rat. Brain Res (2009) 0.89
Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study. Epilepsy Behav (2013) 0.88
Over-expression of N-type calcium channels in cortical neurons from a mouse model of Amyotrophic Lateral Sclerosis. Exp Neurol (2012) 0.88
Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine. Mov Disord (2009) 0.87
Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam. Epilepsia (2007) 0.87
Synaptic plasticity, dopamine and Parkinson's disease: one step ahead. Brain (2009) 0.86
Age-related changes of hippocampal synaptic plasticity in AβPP-null mice are restored by NGF through p75NTR. J Alzheimers Dis (2013) 0.86
Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels' activation in a genetic model of amyotrophic lateral sclerosis. Neurobiol Dis (2007) 0.84
Electrophysiological effects of trace amines on mesencephalic dopaminergic neurons. Front Syst Neurosci (2011) 0.84
GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis. Eur J Neurosci (2008) 0.84
Altered vulnerability to kainate excitotoxicity of transgenic-Cu/Zn SOD1 neurones. Neuroreport (2004) 0.83
Downregulation of thymosin beta4 in neural progenitor grafts promotes spinal cord regeneration. J Cell Sci (2009) 0.82
Effects of simulated microgravity on the development and maturation of dissociated cortical neurons. In Vitro Cell Dev Biol Anim (2004) 0.81
N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATP. Glycobiology (2010) 0.81
Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions. Neuropharmacology (2013) 0.81
A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation. PLoS One (2012) 0.81
Monocyte Chemoattractant Protein-1 upregulates GABA-induced current: evidence of modified GABAA subunit composition in cortical neurons from the G93A mouse model of Amyotrophic Lateral Sclerosis. Neuropharmacology (2013) 0.81
Bindarit, inhibitor of CCL2 synthesis, protects neurons against amyloid-β-induced toxicity. J Alzheimers Dis (2014) 0.80
Synaptic plasticity in the basal ganglia: a similar code for physiological and pathological conditions. Prog Neurobiol (2007) 0.80
CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis? J Sleep Res (2014) 0.80
Cocaine dependence and stroke: pathogenesis and management. Curr Neurovasc Res (2015) 0.80
Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture. Exp Neurol (2010) 0.79
(-)-Linalool attenuates allodynia in neuropathic pain induced by spinal nerve ligation in c57/bl6 mice. Int Rev Neurobiol (2009) 0.79
Dynamic NAD(P)H post-synaptic autofluorescence signals for the assessment of mitochondrial function in a neurodegenerative disease: monitoring the primary motor cortex of G93A mice, an amyotrophic lateral sclerosis model. Mitochondrion (2009) 0.79
Systemic administration of substance P recovers beta amyloid-induced cognitive deficits in rat: involvement of Kv potassium channels. PLoS One (2013) 0.78
The protective role of catalase against cerebral ischemia in vitro and in vivo. Int J Immunopathol Pharmacol (2011) 0.78
Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase. Neurosci Lett (2002) 0.78
The anorexic agents, sibutramine and fenfluramine, depress GABA(B)-induced inhibitory postsynaptic potentials in rat mesencephalic dopaminergic cells. Br J Pharmacol (2009) 0.78
Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration. Neurotox Res (2010) 0.77
A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro. Exp Neurol (2011) 0.77
Effects of phenobarbital and levetiracetam on PR and QTc intervals in patients with post-stroke seizure. Clin Drug Investig (2014) 0.77
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study. J Neurol (2014) 0.77
Complex behavioral and synaptic effects of dietary branched chain amino acids in a mouse model of amyotrophic lateral sclerosis. Mol Nutr Food Res (2011) 0.77
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. CNS Neurol Disord Drug Targets (2016) 0.76
N-ethyl lidocaine (QX-314) protects striatal neurons against ischemia: an in vitro electrophysiological study. Synapse (2010) 0.76
Electroencephalography and dementia: a literature review and future perspectives. CNS Neurol Disord Drug Targets (2013) 0.76
Gene expression profiles of APP and BACE1 in Tg SOD1G93A cortical cells. Cell Mol Neurobiol (2009) 0.76
Tachykinins and excitotoxicity in cerebellar granule cells. Cerebellum (2006) 0.76
Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of Amyotrophic Lateral Sclerosis. Neurobiol Dis (2011) 0.75
AMPA receptors are modulated by tachykinins in rat cerebellum neurons. J Neurophysiol (2005) 0.75
Intermittent short sleep may contribute to orexinergic signaling dysregulation in Alzheimer's Disease. Sleep (2016) 0.75
The midbrain slice preparation. An in vitro model to select potential anti-parkinsonian drugs? Parkinsonism Relat Disord (2008) 0.75